WNT5A and rheumatoid arthritis: We considered particularly notable that treatment with ROCK inhibitor, Y-27632, reduced the activation of p38, ERK MAPK, and PI3K/AKT pathways and completely inhibited the WNT5A induced migration of RA FLS (11).